KPAP Adherence Crossover Study for Obstructive Sleep Apnea
This study is testing a new type of CPAP (Continuous Positive Airway Pressure) therapy called TheraPAP, also known as KPAP, for people with obstructive sleep apnea (OSA). KPAP works by lowering the air pressure during breathing in and part of breathing out, which may make it more comfortable than standard CPAP. Researchers want to see if people use KPAP more often than standard APAP (Automatic Positive Airway Pressure) therapy. To join, you should be between 20 and 80 years old and have moderate to severe sleep apnea. The study will measure how much you use each device over 4-week periods to see which one you use more consistently.
- Study design
- This is a randomized crossover study with 30 participants. You will try both KPAP and APAP therapies for 4 weeks each.
- What's involved
- You will have three office visits and use a device at home nightly for two separate 4-week periods, with a 1-week break in between.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study measures usage over 4-week periods for each therapy arm, but no follow-up beyond the second 4-week period is specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
KPAP Adherence Crossover Study
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- William H Noah, MD · STUDY_DIRECTOR · SleepRes, LLC., Sleep Centers of Middle Tennessee, LLC
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- UsageAveraged over every night for each 4-week arm
Number of hours for which therapy is used per night